Business

Actinogen receives $9.0 million R&D tax incentive rebate

Actinogen receives $9.0 million R&D tax incentive rebate

Actinogen Medical LimitedNovember 11, 20243
Actinogen receives $9.0 million R&D tax incentive rebate

About this update from Actinogen Medical Limited

Actinogen Medical Ltd has released a press release. View Attachment

View stock analysis, news, and events for Actinogen Medical Limited

More from Actinogen Medical Limited

All Actinogen Medical Limited news →